We are pleased to share that Cognivia will take part in the SAPA Annual Conference in Philadelphia on March 21, 2026.
Our CEO, Dominique Demolle, will join the round‑table discussion:
“From Data to ROI: How AI Impacts the Bottom Line of Drug Development.”
Speakers:
- Dominique Demolle, CEO, Cognivia,
- Tifani McCann, PhD, Chief Data & Analytics Officer, Otsuka,
- Haichen Yang, M.D., M.B.A., VP of Clinical Research, Amicus Therapeutics.
This session will explore how AI‑driven insights translate into measurable value across drug development, from operational efficiency to strategic decision‑making.
More information on: sapagp.org/sapa-gp-2026-annual-conference-schedule/